Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy

Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy

Herpes simplex virus (HSV) has proven successful in treating human cancer. Since the approval of talimogene laherparepvec (T-VEC) in 2015, HSV has been thoroughly researched to discover novel mechanisms to combat cancer and treat other diseases. Another HSV-based drug, beremagene geperpavec (B-VEC),...

Full description

Bibliographic Details
Main Authors: Jussi Palomäki, Kiira Kalke, Julius Orpana, Liisa Lund, Fanny Frejborg, Henrik Paavilainen, Hannu Järveläinen, Veijo Hukkanen
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Microorganisms
Subjects:
herpes simplex
cancer
oncolytic virus
extracellular matrix
hyaluronan synthase
naked mole rat
Online Access:https://www.mdpi.com/2076-2607/11/11/2657

Internet

https://www.mdpi.com/2076-2607/11/11/2657

Similar Items